December 5, 2024 - 20:13

In a recent statement, Sam Altman, the CEO of OpenAI, expressed his belief that the emergence of superintelligence will be far more impactful than artificial general intelligence (AGI). Altman suggested that we are only "a few thousand days" away from achieving this advanced form of intelligence, which he predicts will revolutionize various aspects of society.
Superintelligence, according to Altman, represents a level of cognitive capability that exceeds human intelligence in virtually every domain. He emphasized that while AGI is a significant milestone, it is the subsequent leap to superintelligence that will truly reshape industries, economies, and even the fabric of daily life.
The implications of this technology are vast, raising questions about ethics, control, and the future of human labor. As discussions around the potential risks and benefits of superintelligence continue, Altman’s remarks highlight the urgency for proactive measures in governance and regulation to ensure that this powerful technology is developed responsibly.
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...